VC-backed Chinook Therapeutics to merge with Aduro Biotech

Chinook Therapeutics, a Vancouver-based developer of precision medicines for kidney disease, has agreed to merge with Aduro Biotech.

3 June 2020•7 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Canada North America US Healthcare M&A Deals Briefs